tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NXTC Stock Latest News

NextCure Updates ADC Pipeline Progress and Cash Runway
Company AnnouncementsNextCure Updates ADC Pipeline Progress and Cash Runway
21d ago
8K
NXTC
NextCure expects SIM0505 Phase 1 dose escalation data update in Q2
PremiumThe Fly
NextCure expects SIM0505 Phase 1 dose escalation data update in Q2
21d ago
NXTC
Two new option listings and eighteen option delistings on December 22nd
PremiumThe Fly
Two new option listings and eighteen option delistings on December 22nd
2M ago
QD
EPS
NextCure Launches At-The-Market Stock Offering Program
PremiumCompany Announcements
NextCure Launches At-The-Market Stock Offering Program
2M ago
8K
NXTC
NextCure files to sell 2.52M shares of common stock for holders
PremiumThe Fly
NextCure files to sell 2.52M shares of common stock for holders
3M ago
NXTC
NextCure Raises $21.5M in Private Placement
PremiumCompany AnnouncementsNextCure Raises $21.5M in Private Placement
3M ago
8K
NXTC
NextCure announces closing of $21.5M PIPE financing
Premium
The Fly
NextCure announces closing of $21.5M PIPE financing
3M ago
NXTC
Promising Advancements and Strategic Partnerships Drive Buy Rating for NextCure
Premium
Ratings
Promising Advancements and Strategic Partnerships Drive Buy Rating for NextCure
3M ago
NXTC
NextCure prices 2.5M shares at $8.52 in private placement
PremiumThe Fly
NextCure prices 2.5M shares at $8.52 in private placement
3M ago
NXTC
NextCure upgraded to Buy from Neutral at Ladenburg
PremiumThe Fly
NextCure upgraded to Buy from Neutral at Ladenburg
3M ago
NXTC
NextCure Advances Cancer Therapies Amid Financial Adjustments
PremiumCompany Announcements
NextCure Advances Cancer Therapies Amid Financial Adjustments
3M ago
NXTC
NextCure reports Q3 EPS ($3.22), consensus ($3.98)
PremiumThe Fly
NextCure reports Q3 EPS ($3.22), consensus ($3.98)
3M ago
NXTC
NextCure’s Phase I Study of SIM0505: A Potential Breakthrough in Cancer Treatment
PremiumCompany AnnouncementsNextCure’s Phase I Study of SIM0505: A Potential Breakthrough in Cancer Treatment
4M ago
NXTC
NextCure’s Promising Phase 1 Study on LNCB74: A Potential Game-Changer in Cancer Treatment
Premium
Company Announcements
NextCure’s Promising Phase 1 Study on LNCB74: A Potential Game-Changer in Cancer Treatment
4M ago
NXTC
NextCure, Simcere Zaiming announce expansion of Phase 1 trial of SIM0505
Premium
The Fly
NextCure, Simcere Zaiming announce expansion of Phase 1 trial of SIM0505
4M ago
NXTC
NextCure’s Chief Scientific Officer Resigns
PremiumCompany Announcements
NextCure’s Chief Scientific Officer Resigns
6M ago
8K
NXTC
NextCure Reports Q2 2025 Results and Strategic Updates
PremiumCompany Announcements
NextCure Reports Q2 2025 Results and Strategic Updates
6M ago
NXTC
Closing Bell Movers: Intel slides after quarterly report
PremiumThe Fly
Closing Bell Movers: Intel slides after quarterly report
7M ago
EW
ADT
NextCure presents new preclinical data on osteogenesis imperfecta treatment
PremiumThe Fly
NextCure presents new preclinical data on osteogenesis imperfecta treatment
7M ago
NXTC
NextCure files to sell 339,000 shares of common stock for holders
PremiumThe FlyNextCure files to sell 339,000 shares of common stock for holders
7M ago
NXTC
NextCure price target lowered to $15 from $36 at Piper Sandler
Premium
The Fly
NextCure price target lowered to $15 from $36 at Piper Sandler
7M ago
NXTC
NextCure Implements Reverse Stock Split on Nasdaq
Premium
Company Announcements
NextCure Implements Reverse Stock Split on Nasdaq
7M ago
8K
NXTC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >